|
|
Feasibility of en bloc thulium laser enucleation of the prostate in a large case series. Are results enhanced by experience? |
Giovanni Saredia,Giacomo Maria Pirolab,*(),Francesca Ambrosinia,Simone Barbieric,Lorenzo Bertia,Andrea Pacchettid,Domenico Iovinoe,Giuseppe Iettoe,Letizia Libassie,Giulio Carcanoe
|
a Department of Urology, Ospedale di Circolo e Fondazione Macchi, Varese, Italy b Department of Urology, Usl Toscana Sud Est, San Donato Hospital, Arezzo, Italy c Centro Cardiologico Monzino, IRCCS, Milan, Italy d Department of Urology, University of Genova, Genova, Italy e Department of Surgery, University of Insubria, Varese, Italy |
|
|
Abstract Objective: To provide the first large single-operator case series of patients who undergo “en bloc” thulium laser enucleation of the prostate (ThuLEP) and to demonstrate an improvement in enucleation efficacy with experience. Methods: We prospectively evaluated a cohort of patients with symptomatic benign prostatic hyperplasia (BPH) who underwent “en bloc” ThuLEP between May 2015 and November 2017. Association between dependent variables (delivered energy and operating time) and independent variables (adenoma volume and experience) were estimated with regression analysis. The experience was calculated as the time interval between the date of the first operation of the series and the date of the operation being considered. Results: A total of 100 patients were registered for the study. Median operative time was 56.5 min (interquartile range [IQR]: 40-85 min). Median enucleation time was 17.4 min (IQR: 15-21.5 min). Median enucleation index (enucleation time per adenoma gram) was 0.3 min/g (0.2-0.3 min/g). The overall operative time is not influenced by experience, but we registered a significant trend towards a reduction in the total amount of energy delivered energy normalized per adenoma gram (p = 0.0148). Conclusion: We believe that further attention is needed for these new “en bloc” prostatic enucleation techniques, which can facilitate some surgical steps, leading to a widespread use of laser technology for BPH surgical treatment.
|
Received: 29 March 2018
Available online: 04 February 2019
|
Corresponding Authors:
Giacomo Maria Pirola
E-mail: gmo.pirola@gmail.com
|
|
|
Parameter | “en bloc” ThuLEP (n = 100) | Age (year)a | 70.00 ± 7.27 | Prostatic adenoma volume (mL)b | 59 (48, 76) | Prostatic volume in classes, n (min-max) | <60 mL | 52 (20-59) | 60-79 mL | 26 (60-78) | 80-99 mL | 10 (80-99) | 100-120 mL | 8 (100-120) | >120 mL | 4 (132-167) | Indwelling catheterization, n (%) | 24 (26) | IPSS scoreb | 26 (21, 30) | QoLb | 4 (4, 5) | PSA (ng/mL)a | 4.16 ± 8.46 | Qmax (mL/s)a | 8.58 ± 2.80 | PVR (mL)a | 70.00 ± 35.00 | Preoperative Hb (g/dL)b | 14.6 (13.3, 15.5) |
|
Baseline patients'characteristics.
|
Parameter | “en-bloc” ThuLEP (n = 100) | Total surgical time (min)a | 56.5 (40, 85) | Enucleation time (min)a | 17.4 (15, 21.5) | Delivered energy (J)a | 108 652 (88 473, 125 835) | Enucleation index (min/g)a | 0.3 (0.2, 0.3) | Energy index (J/g)a | 6202.5 (5903.2, 6519.4) | Hemoglobin drop (g/dL)a | -1.4 (-1.9, -0.7) | Catheterization (day)ab | 1 (1, 12) | Hospital discharge (day)ab | 1 (1, 2) |
|
Intraoperative characteristics and outcomes of the whole patients' series presented in the study.
|
Complication, grade | Description | n | Management | Clavien Grade I | - Early urinary retention | 3 | Prolonged bladder catheterization | - Clot retention without surgical revision | 3 | Prolonged bladder irrigation | Clavien Grade II | - Massive hematuria | 2 | Transfusions | - Urinary tract infection | 4 | Antibiotic treatment | Clavien Grade IIIb | - Remnant bladder stone | 1 | Reintervention for endoscopic cystolitholapaxy | - Hemorrhage/clot retention | 1 | Cystoscopy, clot evacuation, monopolar coagulation | Total | | 14 | |
|
Analysis of the surgical complications occurred in our series within 30-day perioperative period. Results are reported according to the modified Clavien Grade [8].
|
Parameter | Low experience (n = 33) | Medium experience (n = 33) | High experience (n = 33) | p-Value | Total surgical time (min) | 61.5 (46.5, 89.5) | 55 (41.5, 67.5) | 56.5 (39, 85) | 0.361 | Enucleation time (min) | 18.4 (16, 22.7) | 16.4 (12.3, 20.5) | 17.4 (13.8, 20.3) | 0.299 | Delivered energy (J) | 117 039.5 (102 230, 138 037) | 100 867 (80 053, 118 264) | 102 719.5 (82 284.5, 112 029.5) | 0.054 | Enucleation index (min/g) | 0.3 (0.3, 0.3) | 0.3 (0.2, 0.4) | 0.3 (0.2, 0.4) | 0.325 | Energy index (J/g) | 6476.2 (6054.5, 6594.9) | 6117.4 (5910.9, 6497.8) | 6005.7 (5754.7, 6312.5) | 0.005 | Hemoglobin drop (g/dL) | -1.5 (-2.5, -0.6) | -1.3 (-1.7, -0.7) | -1.4 (-1.8, -0.5) | 0.723 |
|
Intraoperative characteristics and outcomes comparison between the three tertiles of experience (low, medium and high experience).
|
|
The odds ratio (OR) shows that there is 80% less probability of a high energy delivery for medium and high experience compared to the first tertile (low experience). TERZ, tertile; OR1, first tertile of experience; OR2, second tertile of experience; OR3, third tertile of experience.
|
|
ROC curves of the statistical model utilized to describe the effect of experience on the reduction of the total amount of energy, and consequently on the enucleation efficacy. The area under the curve (AUC) is significatively high (0.783). ROC, receiver operating characteristic.
|
Parameter | “en bloc” ThuLEP (n = 100) | p-Value* | IPSS scorea | 3 (1, 6) | <0.001 | Delta IPSSa | -28.0 (-30.5, -21.0) | - | QoLa | 1 (1, 2) | <0.001 | Qmax (mL/s)a | 19 (17, 21) | <0.001 | Delta Qmax (mL/s)b | 14.55 ± 4.6 | - | Postoperative PSA (ng/mL)a | 1.0 (0.6, 1.5) | <0.001 |
|
Follow-up on functional results at 6 months after surgery.
|
[1] |
Lin Y, Wu X, Xu A, Ren R, Zhou X, Wen Y , et al. Transurethral enucleation of the prostate versus transvesical open prostatectomy for large benign prostatic hyperplasia: a systematic review and meta-analysis of randomized controlled trials. World J Urol 2016; 34:1207-19.
|
[2] |
Gravas S, Cornu JN, Drake MJ, Gacci M, Gratzke C, Herrmann TRW , et al. EAU Guidelines on Management of Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO).EAU Guidelines Office, Arnhem, The Netherlands.
|
[3] |
Herrmann TR . Enucleation is enucleation is enucleation is enucleation. World J Urol 2016; 34:1353-5.
|
[4] |
Scoffone CM, Cracco CM . The en-bloc no-touch holmium laser enucleation of the prostate (HoLEP) technique. World J Urol 2016; 34:1175-81.
|
[5] |
Saredi G, Pacchetti A, Pirola GM, Berti L, Ambrosini F, Martorana E , et al. En bloc thulium laser enucleation of the prostate: surgical technique and advantages compared with the classical technique. Urology 2017; 108:207-11.
|
[6] |
Saredi G, Pirola GM, Pacchetti A, Lovisolo JA, Borroni G, Sembenini F , et al. Evaluation of the learning curve for thulium laser enucleation of the prostate with the aid of a simulator tool but without tutoring: comparison of two surgeons with different levels of endoscopic experience. BMC Urol 2015; 15:49.
|
[7] |
Herrmann TR, Bach T, Imkamp F, Georgiou A, Burchardt M, Oelke M , et al. Thulium laser enucleation of the prostate (ThuLEP): transurethral anatomical prostatectomy with laser support. Introduction of a novel technique for the treatment of benign prostatic obstruction. World J Urol 2010; 28:45-51.
|
[8] |
Mamoulakis C, Efthimiou I, Kazoulis S, Christoulakis I, Sofras F . The modified Clavien classifcation system: a standardized platform for reporting complications in transurethral resection of the prostate. World J Urol 2011; 29:205-10.
|
[9] |
Netsch C, Becker B, Tiburtius C, Moritz C, Becci AV, Herrmann TRW , et al. A prospective, randomized trial comparing thulium vapoenucleation with holmium laser enucleation of the prostate for the treatment of symptomatic benign prostatic obstruction: perioperative safety and efficacy. World J Urol 2017; 35:1913-21.
|
[10] |
Pirola GM, Saredi G, Codas Duarte R, Bernard L, Pacchetti A, Berti L , et al. Holmium laser versus thulium laser enucleation of the prostate: a matched-pair analysis from two centers. Ther Adv Urol 2018; 10:223-33.
|
[11] |
Netsch C, Engbert A, Bach T, Gross AJ . Long-term outcome following Thulium VapoEnucleation of the prostate. World J Urol 2014; 32:1551-8.
|
[12] |
Netsch C, Bach T, Herrmann TR, Gross AJ . Update on the current evidence for Tm:YAG vapoenucleation of the prostate 2014. World J Urol 2015; 33:517-24.
|
[13] |
Kim YJ, Lee YH, Kwon JB, Cho SR, Kim JS . A novel one lobe technique of thulium laser enucleation of the prostate: ’Allin- One’ technique. Kor J Urol 2015; 56:769-74.
|
[14] |
Robert G, Cornu JN, Fourmarier M, Saussine C, Descazeaud A, Azzouzi AR , et al. Multicentre prospective evaluation of the learning curve of holmium laser enucleation of the prostate (HoLEP). BJU Int 2016; 117:495-9.
|
[15] |
Shah HN, Mahajan AP, Sodha HS, Hegde S, Mohile PD, Bansal MB . Prospective evaluation of the learning curve for holmium laser enucleation of the prostate. J Urol 2007; 177:1468-74.
|
[16] |
Brunckhorst O, Ahmed K, Nehikhare O, Marra G, Challacombe B, Popert R . Evaluation of the learning curve for holmium laser enucleation of the prostate using multiple outcome measures. Urology 2015; 86:824-9.
|
[17] |
Peyronnet B, Robert G, Comat V, Roupr$\widehat{e}$t M, Gomez-Sancha F, Cornu JN , et al. Learning curves and perioperative outcomes after endoscopic enucleation of the prostate: a comparison between GreenLight 532-nm and holmium lasers. World J Urol 2017; 35:973-83.
|
[18] |
Hirasawa Y, Kato Y, Fujita K . Transurethral enucleation with bipolar for benign prostatic hyperplasia: 2-year outcomes and the learning curve of a single surgeon’s experience of 603 consecutive patients. J Endourol 2017; 31:679-85.
|
[19] |
Herrmann T, Kallidonis P, Kotsiris D, Kyriazis I, Ntasiotis P, Kamal W , et al. Surgeons’ self-assessed learning curve for thulium-assisted laser prostatectomy: evaluation of a nationwide survey. Hellenic Urology 2017; 29:46-53.
|
[1] |
Marcio Covas Moschovas,Frederico Timóteo,Leonardo Lins,Oséas de Castro Neves,Kulthe Ramesh Seetharam Bhat,Vipul R. Patel. Robotic surgery techniques to approach benign prostatic hyperplasia disease: A comprehensive literature review and the state of art[J]. Asian Journal of Urology, 2021, 8(1): 81-88. |
[2] |
Brooke Sachs,Vincent Misrai,Shahin Tabatabaei,Henry H. Woo. Multicenter experience with photoselective vaporization of the prostate on men taking novel oral anticoagulants[J]. Asian Journal of Urology, 2020, 7(4): 340-344. |
[3] |
Renee E. Vickman,Omar E. Franco,Daniel C. Moline,Donald J. Vander Griend,Praveen Thumbikat,Simon W. Hayward. The role of the androgen receptor in prostate development and benign prostatic hyperplasia: A review[J]. Asian Journal of Urology, 2020, 7(3): 191-202. |
[4] |
Dominique Thomas,Kevin C. Zorn,Malek Meskawi,Ramy Goueli,Pierre-Alain Hueber,Lesa Deonarine,Vincent Misrai,Alexis Te,Bilal Chughtai. The role of photovaporization of the prostate in small volume benign prostatic hyperplasia and review of the literature[J]. Asian Journal of Urology, 2019, 6(4): 353-358. |
[5] |
Qixiang Song , Paul Abrams , Yinghao Sun. Beyond prostate, beyond surgery and beyond urology: The “3Bs” of managing non-neurogenic male lower urinary tract symptoms[J]. Asian Journal of Urology, 2019, 6(2): 169-173. |
[6] |
Jie Cao, Xia Sheng, Yan Ding, Lingjuan Zhang, Xiaoying Lu. Effect of warm bladder irrigation fluid for benign prostatic hyperplasia patients on perioperative hypothermia, blood loss and shiver: A meta-analysis[J]. Asian Journal of Urology, 2019, 6(2): 183-191. |
[7] |
Guat Ng Lay. Botulinum toxin and benign prostatic hyperplasia[J]. Asian Journal of Urology, 2018, 5(1): 33-36. |
[8] |
H.Kim Eric,A.Brockman John,L.Andriole Gerald. The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia[J]. Asian Journal of Urology, 2018, 5(1): 28-32. |
[9] |
Xu Peng,Xu Abai,Chen Binshen,Zheng Shaobo,Xu Yawen,Li Hulin,Shen Haiyan,Liu Chunxiao. Bipolar transurethral enucleation and resection of the prostate: Whether it is ready to supersede TURP?[J]. Asian Journal of Urology, 2018, 5(1): 48-54. |
[10] |
Xie Liping,Wang Xiao,Chen Hong,Zheng Xiangyi,Liu Ben,Li Shiqi,Mao Yeqing,Mao Qiqi,Wang Song,Li Jiangfeng,Loch Tillmann. Innovative endoscopic enucleations of the prostate-Xie's Prostate Enucleations[J]. Asian Journal of Urology, 2018, 5(1): 12-16. |
[11] |
Farhad Fakhrudin Vasanwala, Michael Yuet Chen Wong, Henry Sun Sien Ho, Keong Tatt Foo. Benign prostatic hyperplasia and male lower urinary symptoms:A guide for family physicians[J]. Asian Journal of Urology, 2017, 4(3): 181-184. |
[12] |
Keong Tatt Foo. Pathophysiology of clinical benign prostatic hyperplasia[J]. Asian Journal of Urology, 2017, 4(3): 152-157. |
[13] |
Kok Bin Lim. Epidemiology of clinical benign prostatic hyperplasia[J]. Asian Journal of Urology, 2017, 4(3): 148-151. |
[14] |
Rikiya Taoka, Yoshiyuki Kakehi. The influence of asymptomatic inflammatory prostatitis on the onset and progression of lower urinary tract symptoms in men with histologic benign prostatic hyperplasia[J]. Asian Journal of Urology, 2017, 4(3): 158-163. |
[15] |
Kok Kit Ng, Foo Cheong Ng. The use of antimuscarinics, phosphodiesterase type V inhibitors and phytotherapy for lower urinary tract symptoms in men[J]. Asian Journal of Urology, 2017, 4(3): 191-194. |
|
|
|
|